Dojolvi Liquid
NDC Package 69794-050-50

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Dojolvi (triheptanoin) liquids is dOJOLVI is indicated as a source of calories and fatty acids for the treatment of pediatric and adult patients with molecularly confirmed long-chain fatty acid oxidation disorders (LC-FAOD). . This formulation utilizes a liquid delivery system. Marketed by Ultragenyx Pharmaceutical Inc., this product is identified by NDC 69794-050 and is authorized under FDA application NDA213687.

Identification & Billing

NDC Package Code
69794-050-50
Package Description
1 BOTTLE, GLASS in 1 CARTON / 500 mL in 1 BOTTLE, GLASS
Product Code
69794-050
11-Digit Billing Format
69794005050
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Dojolvi
Non-Proprietary Name
Triheptanoin
Substance Name
Triheptanoin
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
TRIHEPTANOIN .96 g/mL
Pharmacologic Class
Usage Information
DOJOLVI is indicated as a source of calories and fatty acids for the treatment of pediatric and adult patients with molecularly confirmed long-chain fatty acid oxidation disorders (LC-FAOD). 

Regulatory & Marketing

Labeler Name
Ultragenyx Pharmaceutical Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA213687
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
07-01-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69794-050-50 identifies a specific commercial package of 1 bottle, glass in 1 carton / 500 ml in 1 bottle, glass of Dojolvi, a human prescription drug labeled by Ultragenyx Pharmaceutical Inc.. This liquid is formulated for oral use and contains triheptanoin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ultragenyx Pharmaceutical Inc. on July 01, 2020. The current certification is valid through December 31, 2026.

How is this Ultragenyx Pharmaceutical Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69794005050. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69794-050-50
11-Digit CMS (5-4-2)
69794-0050-50

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.